牛叉诊股

[{"date":"2026.06.24","stock":"0.71","trade":"-2.01","ind":"1.24"},{"date":"2026.06.23","stock":"2.59","trade":"2.18","ind":"-3.17"},{"date":"2026.06.22","stock":"0.20","trade":"-0.45","ind":"2.13"},{"date":"2026.06.18","stock":"0.47","trade":"-0.26","ind":"0.94"},{"date":"2026.06.17","stock":"-1.06","trade":"-1.01","ind":"1.31"},{"date":"2026.06.16","stock":"-2.07","trade":"-0.94","ind":"0.93"},{"date":"2026.06.15","stock":"1.40","trade":"0.19","ind":"3.79"},{"date":"2026.06.12","stock":"3.15","trade":"1.37","ind":"0.75"},{"date":"2026.06.11","stock":"-1.61","trade":"-1.40","ind":"-0.68"},{"date":"2026.06.10","stock":"1.44","trade":"-0.21","ind":"-2.06"},{"date":"2026.06.09","stock":"1.06","trade":"-0.20","ind":"3.02"},{"date":"2026.06.08","stock":"-1.95","trade":"-2.15","ind":"-3.22"},{"date":"2026.06.05","stock":"1.52","trade":"0.78","ind":"-2.21"},{"date":"2026.06.04","stock":"-1.75","trade":"-1.51","ind":"-0.27"},{"date":"2026.06.03","stock":"-2.09","trade":"-1.25","ind":"0.73"},{"date":"2026.06.02","stock":"-1.19","trade":"-1.13","ind":"1.63"},{"date":"2026.06.01","stock":"-1.60","trade":"1.32","ind":"-1.51"},{"date":"2026.05.29","stock":"1.76","trade":"1.30","ind":"-1.81"},{"date":"2026.05.28","stock":"-2.92","trade":"-0.70","ind":"0.80"},{"date":"2026.05.27","stock":"1.67","trade":"-0.49","ind":"-0.88"},{"date":"2026.05.26","stock":"1.06","trade":"-1.00","ind":"0.12"}]

以岭药业,深证成指,中药指数

压力支撑

该股压力位为15.49元，支撑位为15.21元。

[{"text":"\u538b\u529b\u4f4d","value":"15.49","date":1782230400,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"15.21","date":1782230400,"color":"0x0b52a1"}]

多空趋势

空头行情中，并且有加速下跌的趋势。

macd kdj boll asi bias rsi wr vr

资金面诊股

诊断结果：3.1资金面打败了23%的股票主力控盘前10的股票

资金面得分最高的股票

主力控盘

据统计，近10日内主力没有控盘。

没有控盘
轻度控盘
中度控盘
高度控盘

行业资金

中药行业，近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。

更新时间：06月25日 08:07

机构今日流向(万元)	-1369.97	机构5日流向(万元)	-3251.34
机构10日流向(万元)	-4429.47	机构20日流向(万元)	-9047.81

机构持仓

2025-12-31 与 2025-06-30 相比，主力机构持仓量增加5728.69万股，其中基金净减仓56家，主力净增仓101家，请投资者中长期谨慎为宜。

截止2025-12-31，共333家主力机构（基金330家，其他资管计划1家，一般法人2家），持仓量总计64787万股，占流通A股47.07%
其中，基金持仓与2025-06-30相比：
增仓：52家，增持 864.24万股
减仓：108家，减持 357.74万股
新出现在主力名单中：166家，持有4836.34万股
从主力名单中消失：65家，原持有822.78万股

消息面诊股

诊断结果：5.8消息面打败了19%的股票今日有利好新闻的公司

近期该股消息面总体多空平衡，没有较强的利好或利空趋势。

消息面得分最高的股票

消息列表

一般消息	募资投向		2026-06-05
一般消息	股东大会	年度股东大会	2026-04-28
利好	分红转增	10派5元(含税)	2026-04-28
一般消息	重大事项	关联交易	2026-04-28
利好	业绩预告	预计扭亏	2026-01-23
一般消息	高管变动	取消监事会	2025-12-22
一般消息	重大事项	公司股东股份解押	2025-12-20
一般消息	重大事项	公司股东股份解押	2025-10-18
利好	分红转增	10派3元(含税)	2025-08-28

一年消息统计

	所有消息	重大消息	非重大消息
利好	3条	0条	3条
利空	0条	0条	0条

行业面诊股

诊断结果：5.7行业面打败了85%的股票中药行业最新资金流向

近10日来该行业走势不明显，跑输大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。

行业面得分最高的股票

行业走势

近10日来该行业走势不明显，跑输大盘。

[{"date":"2026.06.24","price":"1.24","value":"-2.01"},{"date":"2026.06.23","price":"-3.17","value":"2.18"},{"date":"2026.06.22","price":"2.13","value":"-0.45"},{"date":"2026.06.18","price":"0.94","value":"-0.26"},{"date":"2026.06.17","price":"1.31","value":"-1.01"},{"date":"2026.06.16","price":"0.93","value":"-0.94"},{"date":"2026.06.15","price":"3.79","value":"0.19"},{"date":"2026.06.12","price":"0.75","value":"1.37"},{"date":"2026.06.11","price":"-0.68","value":"-1.40"},{"date":"2026.06.10","price":"-2.06","value":"-0.21"},{"date":"2026.06.09","price":"3.02","value":"-0.20"},{"date":"2026.06.08","price":"-3.22","value":"-2.15"},{"date":"2026.06.05","price":"-2.21","value":"0.78"},{"date":"2026.06.04","price":"-0.27","value":"-1.51"},{"date":"2026.06.03","price":"0.73","value":"-1.25"},{"date":"2026.06.02","price":"1.63","value":"-1.13"},{"date":"2026.06.01","price":"-1.51","value":"1.32"},{"date":"2026.05.29","price":"-1.81","value":"1.30"},{"date":"2026.05.28","price":"0.80","value":"-0.70"},{"date":"2026.05.27","price":"-0.88","value":"-0.49"},{"date":"2026.05.26","price":"0.12","value":"-1.00"}]

深证成指,中药行业

行业排名

排名	股票名称	1月涨跌幅	5日涨跌幅	评分
1	华森制药	11.79%	11.61%	5.8分
2	康惠股份	9.57%	1.57%	5.2分
3	三力制药	6.67%	-4.04%	5.5分
4	维康药业	4.58%	10.17%	5.1分
5	吉林敖东	2.84%	1.12%	4.9分
6	华润江中	2.67%	-1.11%	5.5分
7	特一药业	2.44%	8.77%	4.3分
8	九芝堂	0.12%	2.01%	5.4分
9	ST百灵	0.00%	6.36%	4.8分
10	以岭药业	-0.64%	2.91%	5.2分
11	粤万年青	-1.08%	8.51%	3.9分
12	步长制药	-1.11%	-3.27%	4.9分
13	华润三九	-1.14%	-3.71%	5.4分
14	康恩贝	-1.47%	1.01%	5.4分
15	天士力	-1.64%	-2.81%	4.8分
16	众生药业	-1.74%	6.13%	5.4分
17	佐力药业	-1.99%	1.14%	5.2分
18	白云山	-2.04%	-2.27%	5.3分
19	亚宝药业	-2.11%	-2.59%	4.4分
20	云南白药	-2.50%	-3.60%	5.7分
21	佛慈制药	-2.52%	-3.03%	4.7分
22	-	-2.73%	0.65%	分
23	羚锐制药	-3.32%	-4.26%	5.2分
24	仁和药业	-4.25%	-1.52%	4.5分
25	桂林三金	-4.27%	1.29%	5.5分
26	昆药集团	-4.27%	-3.70%	4.5分
27	达仁堂	-4.72%	-0.78%	5.0分
28	马应龙	-4.78%	-2.45%	4.7分
29	盘龙药业	-4.94%	-1.59%	4.4分
30	-	-5.16%	-2.30%	分
31	精华制药	-5.26%	1.09%	4.9分
32	方盛制药	-5.40%	-0.94%	5.4分
33	振东制药	-5.66%	-3.59%	4.4分
34	汉森制药	-5.70%	-1.00%	4.6分
35	千金药业	-5.73%	0.10%	4.9分
36	康缘药业	-5.83%	-3.73%	4.5分
37	济川药业	-5.89%	1.02%	5.2分
38	*ST香雪	-5.90%	2.35%	4.1分
39	葵花药业	-6.34%	-2.34%	4.9分
40	红日药业	-6.52%	-1.63%	4.0分
41	奇正藏药	-6.87%	-1.60%	4.8分
42	天目药业	-7.71%	2.51%	4.4分
43	东阿阿胶	-8.39%	-7.59%	4.6分
44	太龙药业	-9.01%	-12.72%	4.6分
45	同仁堂	-9.04%	-5.83%	3.9分
46	广誉远	-9.56%	-2.17%	4.8分
47	健民集团	-9.80%	6.22%	5.4分
48	信邦制药	-9.87%	-2.49%	4.4分
49	沃华医药	-9.92%	-2.32%	4.8分
50	陇神戎发	-10.21%	-2.76%	4.6分
51	寿仙谷	-10.44%	-9.93%	4.7分
52	新光药业	-10.96%	-1.71%	4.7分
53	片仔癀	-11.02%	-5.75%	4.6分
54	ST嘉应	-11.57%	-10.58%	4.3分
55	益盛药业	-11.71%	-4.04%	5.1分
56	益佰制药	-12.01%	-2.78%	4.1分
57	太极集团	-12.15%	-4.77%	4.3分
58	古汉医药	-12.89%	-3.78%	4.5分
59	华神科技	-12.90%	-3.24%	5.0分
60	ST金花	-13.81%	-7.04%	4.7分
61	新天药业	-14.11%	-3.40%	4.4分
62	中恒集团	-14.41%	-4.52%	4.1分
63	康美药业	-14.84%	-2.94%	3.7分
64	ST万邦	-15.84%	-5.37%	5.5分
65	上海凯宝	-18.27%	-3.34%	3.4分
66	ST葫芦娃	-19.57%	-10.21%	3.6分
67	恩威医药	-22.80%	4.46%	4.6分
68	珍宝岛	-42.13%	-16.79%	3.5分

<上一页 1 2 3 4 5...12 下一页>

行业评级

最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。

综合评级

研究机构	评级日期	最新评级	上次评级
中信证券	2012-09-10	增持	增持
招商证券	2012-09-08	增持	增持
航天证券	2012-09-06	增持	-
中银国际	2012-09-05	增持	-
齐鲁证券	2012-09-05	增持	-

基本面诊股

诊断结果：7.7基本面打败了97%的股票连续3年业绩增长30%的公司

该公司运营状况良好，多数机构认为该股长期投资价值较高。

个股深一度

潜在高分红能力：弱（82.5分）

基本面得分最高的股票

[ 截止日期：2026-03-31 ]公司经营

盈利能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 20/107 ， 26/107。

[{"date":"2026-03-31","value":"3.65","vol":"2.21"},{"date":"2025-12-31","value":"12.13","vol":"-2.33"},{"date":"2025-09-30","value":"9.56","vol":"4.80"},{"date":"2025-06-30","value":"6.34","vol":"4.03"},{"date":"2025-03-31","value":"3.14","vol":"2.24"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
净资产收益率(%)	3.65	12.13	9.56	6.34	3.14
行业(%)	2.21	-2.33	4.80	4.03	2.24

该指标值越高，盈利能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"60.05","vol":"55.05"},{"date":"2025-12-31","value":"64.28","vol":"52.85"},{"date":"2025-09-30","value":"60.53","vol":"53.29"},{"date":"2025-06-30","value":"59.48","vol":"53.82"},{"date":"2025-03-31","value":"53.82","vol":"54.48"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
销售毛利率(%)	60.05	64.28	60.53	59.48	53.82
行业(%)	55.05	52.85	53.29	53.82	54.48

该指标值越高，盈利能力越强，行业排名越靠前。

成长能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 23/107 ， 17/107。

[{"date":"2026-03-31","value":"3.46","vol":"-5.58"},{"date":"2025-12-31","value":"20.24","vol":"-6.76"},{"date":"2025-09-30","value":"-7.82","vol":"-7.84"},{"date":"2025-06-30","value":"-12.26","vol":"-7.78"},{"date":"2025-03-31","value":"-6.52","vol":"-7.40"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
营业收入同比增长率(%)	3.46	20.24	-7.82	-12.26	-6.52
行业(%)	-5.58	-6.76	-7.84	-7.78	-7.40

该指标值越高，成长能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"25.43","vol":"1.06"},{"date":"2025-12-31","value":"277.56","vol":"-80.25"},{"date":"2025-09-30","value":"80.33","vol":"-2.78"},{"date":"2025-06-30","value":"26.03","vol":"2.25"},{"date":"2025-03-31","value":"7.25","vol":"-37.69"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
净利润同比增长率(%)	25.43	277.56	80.33	26.03	7.25
行业(%)	1.06	-80.25	-2.78	2.25	-37.69

该指标值越高，成长能力越强，行业排名越靠前。

营运能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 9/107 ， 21/107。

[{"date":"2026-03-31","value":"0.18","vol":"0.12"},{"date":"2025-12-31","value":"0.58","vol":"0.47"},{"date":"2025-09-30","value":"0.43","vol":"0.35"},{"date":"2025-06-30","value":"0.30","vol":"0.24"},{"date":"2025-03-31","value":"0.17","vol":"0.13"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
总资产周转率(次)	0.18	0.58	0.43	0.30	0.17
行业(次)	0.12	0.47	0.35	0.24	0.13

该指标值越高，营运能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"0.69","vol":"0.59"},{"date":"2025-12-31","value":"1.73","vol":"2.34"},{"date":"2025-09-30","value":"1.35","vol":"1.72"},{"date":"2025-06-30","value":"1.02","vol":"1.17"},{"date":"2025-03-31","value":"0.70","vol":"0.59"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
存货增长率(次)	0.69	1.73	1.35	1.02	0.70
行业(次)	0.59	2.34	1.72	1.17	0.59

该指标值越高，营运能力越强，行业排名越靠前。

现金流能力：数据暂时不全，请后续关注

[{"date":"2026-03-31","value":"25.03","vol":"5.83"},{"date":"2025-12-31","value":"25.38","vol":"30.77"},{"date":"2025-09-30","value":"24.42","vol":"10.53"},{"date":"2025-06-30","value":"29.25","vol":"22.82"},{"date":"2025-03-31","value":"14.42","vol":"2.06"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
现金流量净额/营业收入	25.03	25.38	24.42	29.25	14.42
行业	5.83	30.77	10.53	22.82	2.06

该指标值越高，现金流能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"0.39","vol":"1.00"},{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"0.29","vol":"1.03"},{"date":"2025-03-31","value":"","vol":"0.00"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
资本支出／折旧和摊销	-	0.39	-	0.29	-
行业	0.00	1.00	0.00	1.03	0.00

该指标值越低，现金流能力越强，行业排名越靠前。

短期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 24/107 ， 39/107。

[{"date":"2026-03-31","value":"2.50","vol":"2.97"},{"date":"2025-12-31","value":"2.36","vol":"2.94"},{"date":"2025-09-30","value":"1.85","vol":"3.09"},{"date":"2025-06-30","value":"2.05","vol":"2.94"},{"date":"2025-03-31","value":"1.80","vol":"3.03"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
流动比率	2.50	2.36	1.85	2.05	1.80
行业	2.97	2.94	3.09	2.94	3.03

该指标值越接近2，短期偿债能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"1.87","vol":"2.23"},{"date":"2025-12-31","value":"1.60","vol":"2.15"},{"date":"2025-09-30","value":"1.24","vol":"2.24"},{"date":"2025-06-30","value":"1.41","vol":"2.15"},{"date":"2025-03-31","value":"1.22","vol":"2.24"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
速动比率	1.87	1.60	1.24	1.41	1.22
行业	2.23	2.15	2.24	2.15	2.24

该指标值越接近1，短期偿债能力越强，行业排名越靠前。

长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 47/107 ， 48/107。

[{"date":"2026-03-31","value":"19.66","vol":"31.94"},{"date":"2025-12-31","value":"19.69","vol":"32.43"},{"date":"2025-09-30","value":"24.77","vol":"31.59"},{"date":"2025-06-30","value":"21.81","vol":"32.45"},{"date":"2025-03-31","value":"23.13","vol":"31.91"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
资产负债率(%)	19.66	19.69	24.77	21.81	23.13
行业(%)	31.94	32.43	31.59	32.45	31.91

该指标值越接近50%，长期偿债能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"0.24","vol":"0.66"},{"date":"2025-12-31","value":"0.25","vol":"0.67"},{"date":"2025-09-30","value":"0.33","vol":"0.76"},{"date":"2025-06-30","value":"0.28","vol":"0.75"},{"date":"2025-03-31","value":"0.30","vol":"0.74"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
产权比率 (%)	0.24	0.25	0.33	0.28	0.30
行业(%)	0.66	0.67	0.76	0.75	0.74

该指标值越高，长期偿债能力越强，行业排名越靠前。

机构评级

最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。

研究机构	评级日期	最新评级	上次评级
华泰证券	2026-05-25	买入	买入
中信建投证券	2026-05-22	买入	买入
华创证券	2026-05-14	增持
长城证券	2026-05-07	买入
国联民生	2026-05-02	买入
国泰海通证券	2026-05-02	买入

机构预测

机构预测该股2026年每股收益与前一年相同，长期投资价值一般。

[{"date":"2022","yellowRectValue":"23.63","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"13.52","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"-7.25","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"12.86","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"15.04","blueLineValue":"0.90","type":"YC"}]

[以岭药业]

技术面诊股
资金面诊股
消息面诊股
行业面诊股
基本面诊股

【数据基于历史，不代表未来趋势；诊股基于模型与测试，需要投资者根据不同行情合理运用、独立判断、控制风险】

证券咨询服务提供：浙江同花顺云软件有限公司 [编号：zx0050]